Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-20

Clinical Trial Update: Study with Norucholic Acid Tablets in Patients with Primary Sclerosing Cholangitis (PSC) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Norucholic Acid Tablets for Primary Sclerosing Cholangitis; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Norucholic Acid Tablets (norucholic acid)

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Primary Sclerosing Cholangitis | Phase 3 | Status: NOT_YET_RECRUITING